FLSM
Frazier Life Sciences Management’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.6M | Hold |
1,397,527
| – | – | 2.26% | 10 |
|
|
2025
Q1 | $71.8M | Sell |
1,397,527
-190,000
| -12% | -$9.76M | 3.28% | 8 |
|
|
2024
Q4 | $87.9M | Hold |
1,587,527
| – | – | 3.65% | 10 |
|
|
2024
Q3 | $52.2M | Hold |
1,587,527
| – | – | 2.09% | 15 |
|
|
2024
Q2 | $43.1M | Sell |
1,587,527
-200,000
| -11% | -$5.44M | 2.02% | 15 |
|
|
2024
Q1 | $65M | Hold |
1,787,527
| – | – | 2.74% | 11 |
|
|
2023
Q4 | $36.2M | Hold |
1,787,527
| – | – | 1.94% | 15 |
|
|
2023
Q3 | $31.8M | Hold |
1,787,527
| – | – | 2.11% | 13 |
|
|
2023
Q2 | $32.3M | Hold |
1,787,527
| – | – | 1.93% | 13 |
|
|
2023
Q1 | $22.5M | Hold |
1,787,527
| – | – | 1.63% | 17 |
|
|
2022
Q4 | $26.2M | Hold |
1,787,527
| – | – | 1.63% | 15 |
|
|
2022
Q3 | $30.6M | Hold |
1,787,527
| – | – | 2.36% | 12 |
|
|
2022
Q2 | $26.1M | Buy |
1,787,527
+370,370
| +26% | +$5.41M | 2.46% | 12 |
|
|
2022
Q1 | $23.8M | Buy |
+1,417,157
| New | +$23.8M | 2.03% | 15 |
|